Rad GTPase induces cardiomyocyte apoptosis through the activation of p38 mitogen-activated protein kinase

Biochemical and Biophysical Research Communications

Volumn 409, Issue 1, 2011, Pages 52-57

  Sun, Zhongcui ^a,b   Zhang, Ji ^b   Zhang, Jifeng ^c   Chen, Chunlei ^b   Du, Quan ^b   Chang, Lin ^c   Cao, Chunmei ^b   Zheng, Ming ^b   Garcia Barrio, Minerva T ^d   Chen, Yuqing E ^c   Xiao, Rui Ping ^b   Mao, Jieming ^a   Zhu, Xiaojun ^b  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c UNIVERSITY OF MICHIGAN   (United States)

^d MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Bcl xL; Cardiomyocyte; P38 MAPK; Rad GTPase

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BETA ACTIN; DNA FRAGMENT; GUANOSINE TRIPHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BCL XL; PROTEIN RAD; TUBULIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; HEART MUSCLE CELL; NEWBORN; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; RAT;

ANIMALS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; IMIDAZOLES; MYOCYTES, CARDIAC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; PYRIDINES; RAS PROTEINS; RATS; RNA, SMALL INTERFERING;

RATTUS;

EID: 79956189399     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.04.104     Document Type: Article

References (32)

1. Kelly K. The RGK family: a regulatory tail of small GTP-binding proteins. Trends Cell Biol. 2005, 15:640.
2. Reynet C., Kahn C.R. Rad: a member of the Ras family overexpressed in muscle of type II diabetic humans. Science 1993, 262:1441-1444.
3. Moyers J.S., Bilan P.J., Reynet C., Kahn C.R. Overexpression of Rad inhibits glucose uptake in cultured muscle and fat cells. J. Biol. Chem. 1996, 271:23111-23116.
4. Ilany J., Bilan P.J., Kapur S., Caldwell J.S., et al. Overexpression of Rad in muscle worsens diet-induced insulin resistance and glucose intolerance and lowers plasma triglyceride level. Proc. Natl. Acad. Sci. USA 2006, 103:4481-4486.
5. Moyers J.S., Bilan P.J., Zhu J., Kahn C.R. Rad and Rad-related GTPases interact with calmodulin and calmodulin-dependent protein kinase II. J. Biol. Chem. 1997, 272:11832-11839.
6. P. Beguin, R.N. Mahalakshmi, K. Nagashima, D.H. Cher, et al., Nuclear sequestration of beta-subunits by Rad and Rem is controlled by 14-3-3 and calmodulin and reveals a novel mechanism for Ca(2+) channel regulation. J. Mol. Biol. (2005).
7. Fu M., Zhang J., Tseng Y.H., Cui T., et al. Rad GTPase attenuates vascular lesion formation by inhibition of vascular smooth muscle cell migration. Circulation 2005, 111:1071-1077.
8. Ward Y., Yap S.F., Ravichandran V., Matsumura F., et al. The GTP binding proteins Gem and Rad are negative regulators of the Rho-Rho kinase pathway. J. Cell Biol. 2002, 157:291-302.
9. Finlin B.S., Crump S.M., Satin J., Andres D.A. Regulation of voltage-gated calcium channel activity by the Rem and Rad GTPases. Proc. Natl. Acad. Sci. USA 2003, 100:14469-14474.
10. Wang G., Zhu X., Xie W., Han P., et al. Rad as a novel regulator of excitation-contraction coupling and {beta}-adrenergic signaling in heart. Circ. Res. 2010, 106:317-327.
11. Yada H., Murata M., Shimoda K., Yuasa S., et al. Dominant negative suppression of Rad leads to QT prolongation and causes ventricular arrhythmias via modulation of L-type Ca2+ channels in the heart. Circ. Res. 2007, 101:69-77.
12. Chang L., Zhang J., Tseng Y.H., Xie C.Q., et al. Rad GTPase deficiency leads to cardiac hypertrophy. Circulation 2007, 116:2976-2983.
13. Zhang J., Chang L., Chen C., Zhang M., et al. Rad GTPase inhibits cardiac fibrosis through connective tissue growth factor. Cardiovasc. Res. 2011, 10.1093/cvr/cvr068.
14. Brown J.H., Del Re D.P., Sussman M.A. The Rac and Rho hall of fam: a decade of hypertrophic signaling hits. Circ. Res. 2006, 98:730-742.
15. Budzyn K., Marley P.D., Sobey C.G. Targeting Rho and Rho-kinase in the treatment of cardiovascular disease. Trends Pharmacol. Sci. 2006, 27:97.
16. Ren J., Fang C.X. Small guanine nucleotide-binding protein Rho and myocardial function. Acta Pharmacol. Sin. 2005, 26:279-285.
17. Shen T., Zheng M., Cao C., Chen C., et al. Mitofusin-2 is a major determinant of oxidative stress-mediated heart muscle cell apoptosis. J. Biol. Chem. 2007, 282:23354-23361.
18. Zhu X., Lin Y., Zhang J., Fu M., et al. Thiazolidinediones, a class of anti-diabetic drugs, inhibit Id2 expression through a PPARgamma-independent pathway in human aortic smooth muscle cells. Cell. Mol. Life Sci. 2003, 60:212-218.
19. Baines C.P., Molkentin J.D. STRESS signaling pathways that modulate cardiac myocyte apoptosis. J. Mol. Cell. Cardiol. 2005, 38:47-62.
20. Barki-Harrington L., Perrino C., Rockman H.A. Network integration of the adrenergic system in cardiac hypertrophy. Cardiovasc. Res. 2004, 63:391-402.
21. Abbate A., Bussani R., Amin M.S., Vetrovec G.W., et al. Acute myocardial infarction and heart failure: role of apoptosis. Int. J. Biochem. Cell Biol. 2006, 38:1834-1840.
22. Ito M., Adachi T., Pimentel D.R., Ido Y., et al. Statins inhibit {beta}-adrenergic receptor-stimulated apoptosis in adult Rat ventricular myocytes via a Rac1-dependent mechanism. Circulation 2004, 110:412-418.
23. Del Re D.P., Miyamoto S., Brown J.H. RhoA/Rho kinase up-regulate Bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis. J. Biol. Chem. 2007, 282:8069-8078.
24. Crow M.T., Mani K., Nam Y.-J., Kitsis R.N. The mitochondrial death pathway and cardiac myocyte apoptosis. Circ. Res. 2004, 95:957-970.
25. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993, 74:609-619.
26. Ma X.L., Kumar S., Gao F., Louden C.S., et al. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 1999, 99:1685-1691.
27. Porras A., Zuluaga S., Black E., Valladares A., et al. P38 alpha mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol. Biol. Cell 2004, 15:922-933.
28. Mackay K., Mochly-Rosen D. An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia. J. Biol. Chem. 1999, 274:6272-6279.
29. Zhang S., Han J., Sells M.A., et al. Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. J. Biol. Chem. 1995, 270:23934-23936.
30. Bagrodia S., Dérijard B., Davis R.J., Cerione R.A. Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation. J. Biol. Chem. 1995, 270:27995-27998.
31. Ren J., Zhang S., Kovacs A., Wang Y., et al. Role of p38[alpha] MAPK in cardiac apoptosis and remodeling after myocardial infarction. J. Mol. Cell. Cardiol. 2005, 38:617-623.
32. Ren J., Zhang S., Kovacs A., Wang Y., et al. Role of p38[alpha] MAPK in cardiac apoptosis and remodeling after myocardial infarction. J. Mol. Cell. Cardiol. 2005, 38:617.